Dilip Shanghvi to buy 23 per cent stake in Suzlon for USD 290 million
Dilip Sanghvi, the founder of Sun Pharmaceutical Industries, has agreed to buy a 23 per cent stake in Indian wind...
Dilip Sanghvi, the founder of Sun Pharmaceutical Industries, has agreed to buy a 23 per cent stake in Indian wind...
Sun Pharmaceutical Industries, the drug major, on Saturday reported a 6.92 per cent decline in its consolidated net profit at...
Cipla, the pharmaceutical firm, on Thursday reported 15.31 per cent increase in its consolidated net profit at Rs 327.85 crore...
Pfizer Inc. (NYSE: PFE) and Hospira, Inc. (NYSE: HSP) have entered into a definitive merger agreement under which Pfizer will...
French pharma major Sanofi is investing Rs 460 crore to set up a new insulin facility in Hyderabad and augment...
The healthcare landscape has entered a period of rapid change not seen in many years. There is now an intense...
Salix Pharamaceuticals and Indian pharmaceutical company Lupin announced Friday that they have entered into a distribution agreement that grants Lupin...
Hungarian pharmaceutical company HYD Pharma has just completed a HUF 250 mln research phase in the development of a new...
Gilead Sciences entered into an non-exclusive licencing agreements with seven India-based generic pharma manufacturers to expand access to its chronic...
Takeda Pharmaceuticals USA and Orexigen Therapeutics have received approval from the US Food and Drug Administration (FDA) for a...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.